Research Antibodies Market Research - Global Forecasts from 2024 to 2029: Expanding Requirement for Personalised Medication and Structure-based Medication Plans to Bolster Growth
June 24, 2024 10:17 ET
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global research...
Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
June 11, 2024 09:14 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...
Global Immunoglobulin Products Market Report 2024-2028: Increasing Adoption of Subcutaneous Administration and Growing Focus on Personalized Medicine to Lead to Sizable Demand in the Market
June 04, 2024 04:02 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Immunoglobulin Products Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The global immunoglobulin products...
Global Convalescent Plasma Therapy Market to Grow at a CAGR of 11.8% from 2023 to 2024
March 28, 2024 18:03 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Convalescent Plasma Therapy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market InsightsThe global market...
Plasma Fractionation Market to reach USD 42.6 billion by 2031, Expanding at a CAGR of 6.7%: Transparency Market Research, Inc.
March 06, 2024 08:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 06, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global plasma fractionation market is estimated to flourish at a CAGR of 6.7% from...
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Industry Forecast to 2032: U.S. Projected to Maintain Dominance, Driven by Innovative Therapies Entering the Market
January 30, 2024 07:43 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032" report has been added to ...
Primary Immunodeficiency Therapeutics Market to Surpass $11 Billion by 2030 with Significant Advancement in Genetic Research and Diagnostic Technologies
January 24, 2024 12:27 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Primary Immunodeficiency Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
Global Research Antibodies Analysis Report 2024: Emerging Opportunities with Expansion into Emerging Countries and Development of Novel Research Antibodies - Forecasts to 2028
January 17, 2024 04:23 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering. The global market for research antibodies was...
Global Antibody Therapeutic Market Research Report 2024-2033 Featuring Key Players - AbbVie, Amgen, Johnson & Johnson Services, Eli Lilly and Co, and Hoffmann-La Roche
January 05, 2024 04:53 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and...
Plasma Fractionation Market Research Report 2023: Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC - Global Forecast to 2028
November 28, 2023 10:23 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology,...